Combination Antibiotic-Steroid for Ocular Inflammation Filed for FDA Approval結合抗生素類固醇眼發炎申請FDA批准
ISTA Pharmaceuticals Inc., which develops eye-care treatments said Thursday it filed a new drug application with the US Food and Drug Administration for its combination antibiotic steroid to fight ocular inflammation.土改製藥公司，這兩家公司的發展，眼保健治療週四表示，它提出了一個新的藥物的應用與美國食品和藥物管理局及其組合的抗生素類固醇，以爭取眼部發炎。
The topical product, called T-Pred, is a combination of tobramycin and prednisolone acetate.熱門產品，稱為T了預測，是一個結合妥布黴素和醋酸潑尼松龍。
The company finished a Phase III clinical trial of the treatment candidate during the fourth quarter of 2005.該公司完成了三期臨床試驗的治療候選人，在2005年第四季度。 ISTA expects to launch the drug in mid-2007 if it is approved.土改預計發射藥在2007年年中，如果它是獲得批准。
You may also like to read您可能還喜歡讀
- Phase II Clinical Trial of Mifepristone an Eye Drop Treatment for Steroid Associated Elevated Intraocular Pressure第二期臨床試驗米非司酮一種眼藥水治療類固醇相關的高眼壓
- Antibiotic Fights Lymphoma of Eye Linked to Chlamydia抗生素打架淋巴瘤的眼睛相連衣原體
- Antibiotics Alone No Match for Blinding Eye Infection Trachoma抗生素僅仍舊不能致盲眼科感染沙眼
- Mysterious Post Operative Eye Infection (TASS) Swept Across the Continent神秘手術後眼睛感染（衣）席捲大陸
- Single Mass Antibiotic Treatment Is Not Enough To Treat And Eliminate Trachoma單大規模的抗生素治療是不夠的，以治療和消除沙眼
- Alcon Gets FDA Approval for Travatan-Z Which Reduce Elevated Intraocular Pressure alcon獲得FDA批准travatan - Z的，其中減少高眼壓
- Dry Eye Treatment by Omega Fatty Acids in Combination with Artificial Tears乾眼症的治療奧米加脂肪酸結合人工淚液
- Reappearance of Inturned Eyelashes May be Prevented by Azithromycin再現inturned睫毛，可阻止阿奇黴素
- Beware of Sandoz Prednisolone 1% Ophthalmic Suspension due to potential health risk提防桑強的松1 ％眼科停牌因健康構成潛在的危險
- Pfizer Antibiotic Zithromax for Eye Infection May Bring Re-Infections輝瑞抗生素希舒美眼科感染可能帶來重新感染
